𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levodopa induces dyskinesias in normal squirrel monkeys

✍ Scribed by Daniel M. Togasaki; Louis Tan; Peter Protell; Donato A. Di Monte; Maryka Quik; J. William Langston


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
823 KB
Volume
50
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Amantadine reduces levodopa-induced dysk
✍ Pierre J. Blanchet; Spyridon Konitsiotis; Thomas N. Chase πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 465 KB

The antidyskinetic potential of the glutamate NMDA receptor channel blocker amantadine was evaluated in four levodopa-primed parkinsonian monkeys using two different regimens (1.25 or 2.5 mg/kg administered subcutaneously twice daily for 3-6 days). When administered with a relatively low dose of lev

Nondopaminergic mechanisms in levodopa-i
✍ Jonathan M. Brotchie πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 119 KB

## Abstract It has become increasingly apparent that Parkinson's disease involves many transmitter systems other than dopamine. This nondopaminergic involvement impacts on the generation of symptoms, on the neurodegenerative process, but, most tellingly, in the generation of side effects of current

BDNF levels are not related with levodop
✍ Pershia Samadi; Marc Morissette; Daniel LΓ©vesque; ThΓ©rΓ¨se Di Paolo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 438 KB

## Abstract Levodopa‐induced dyskinesias (LIDs) are frequent in parkinsonian patients and may result from an aberrant plasticity. Brain‐derived neurotrophic factor (BDNF) represents a likely candidate to subserve neuroadaptive processes encountered in LIDs. We compared striatal BDNF levels measured